Abstract
Background: External immunoscintigraphy using a single monoclonal antibody has been employed successfully to localize primary, recurrent, and occult colorectal carcinoma. This prospective study investigated the accuracy and sensitivity of external immunoscintigraphy when the combination or “cocktail” of radiolabeled monoclonal antibodies, CYT-103 (an IgG1a) and CYT-372 (an IgG2b) directed against TAG-72 and CEA, respectively, is given to patients with known or suspected colorectal cancer.
Methods: Eleven patients enrolled in this open label phase I/II study underwent preoperative external immunoscintigraphy after intravenous cocktail administration of two indium 111-labeled monoclonal antibodies (MoAb), CYT103 and CYT372. Antibody dose ranged from 0.2 mg (five patients) to 1.0 mg (six patients), each antibody radiolabeled with 2.5 mCi of indium 111, delivering a total dose of 5 mCi per patient. Planar and SPECT images were performed 2 to 5 days postinjection. Suspected lesions were surgically resected within 2 weeks of injection.
Results: A total of 23 lesions (sites) were identified in the eleven patients, 19 of which were confirmed by pathology (hematoxylin and eosin [H&E]). Cocktail immunoscintigrams identified 16 of the 19 confirmed lesions. Computed tomography (CT) scan detected 9 of the 19 lesions. The sensitivities of cocktail immunoscintigraphy and CT scan for the detection of colorectal cancer were 84% and 64%, respectively. The positive predictive value for immunoscintigraphy was 94%. The antibody scans detected six occult, previously unsuspected lesions. Cocktail immunoscintigraphy changed the surgical management in four of the 11 (36%) patients.
Conclusions: The combination of In 111 CYT-103 and CYT-372 improved the sensitivity of external immunoscintigraphy for the detection of colorectal cancer compared to that obtained with a single MoAb imaging. Cocktail antibody imaging may enhance the staging and management of patients with cancers of colon and rectum.
Similar content being viewed by others
References
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998.CA Cancer J Clin 1998;48:10.
Bertsch DJ, Burak WE, Young DC, Arnold MW, Martin EW. Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancer.Surgery 1995;118:634–9.
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer.N Engl J Med 1997;336:980–7.
Moertel CG, Fleming TR, MacDonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.N Engl J Med 1990;322:352–8.
Rodriguez-Bigas MA, Bakshi S, Stomper P, Blumenson LE, Petrelli NJ.99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.Arch Surg 1992;127:1321–4.
Doerr RJ, Abdel-Nabi H, Merchant B. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.Arch Surg 1990;125:226–9.
Halpern SE, Dillman RO, Amox D, et al. Detection of occult tumor using indium 111-labeled anticarcinoembryonic antigen antibodies.Arch Surg 1992;127:1094–1100.
Doerr RJ, Abdel-Nabi H, Krag D, Mitchell E. Radiolabeled antibody imaging in the management of colorectal cancer.Ann Surg 1991;214:118–24.
Rodwell JD, Alvarez VL, Lee C, et al. Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.Proc Natl Acad Sci USA 1986;83:2632–6.
Simpson JF, Primus FJ, Schlom J. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.Int J Biol Markers 1991;6:83–90.
Pressman D, Day ED, Blau M. The use of paired labeling in the determination of tumor-localizing antibodies.Cancer Res 1957;17:845–50.
Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system.J Exp Med 1965;122:467–81.
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity.Nature 1975;256:495–7.
Block GE, Collier BD, Doerr RJ, Martin EW, McKearn TJ, Thurston MO. Symposium on the practical applications for immunoscintigraphy in the surgical management of colorectal cancer.Contemp Surg 1993;42:287–311.
Arnold MW, Schneebaum S, Berens A, Petty L, Mojzisik C, Hinkle, Martin EW. Intraoperative detection of colorectal cancer with radioimmunoguided surgery and CC49, a second-generation monoclonal antibody.Ann Surg 1992;216:627–32.
Schneebaum S, Papo J, Graif M, Baratz M, Baron J, Skornik Y. Radioimmunoguided surgery benefits for recurrent colorectal cancer.Ann Surg Oncol 1997;4:371–6.
Tagliabue E, Porro G, Barbanti P, et al. Improvement of tumor cell detection using a pool of monoclonal antibodies.Hybridoma 1986;5:107–15.
Collier BD, Abdel-Nabi H, Doerr RJ, et al. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.Radiology 1992;185:179–86.
Nabi H, Doerr RJ, Balu D, Farrell E, Evans N. Colorectal carcinoma imaging with IN-111 Mab C46.3-GYK-DTPA (CYT-372). Preliminary clinical results.Eur J Nucl Med 1993;20:874. Abstract.
Abdel-Nabi HH, Schwartz AN, Goldfogel G, Ortman-Nabi JA, Matsuoka DM, Unger MW, Wechter DG. Colorectal tumors: Scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.Radiology 1988;166:747–52.
Quinlan D, Davidson A, Gamponia E, Lindley J, Doshi H. Detection of tumor-associated glycoprotein-72 (TAG-72) in short-term and long-term surviving colon cancer patients using a first-and second-generation monoclonal antibody.Proc Am Assoc Cancer Res 1991;32:271.
Volpe CM, Rodriguez-Bigas M, Petrelli NJ. Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma.Cancer Invest 1996;14:1–5.
Cohen AM, Minsky BD, Schilsky RL. Colon cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia: JB Lippincott, 1993:929–77.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Volpe, C.M., Abdel-Nabi, H.H., Kulaylat, M.N. et al. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer. Annals of Surgical Oncology 5, 489–494 (1998). https://doi.org/10.1007/BF02303640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02303640